News and insights in

Rosalind Study

Happy 14 Juillet! French oncology centers are an important part of our oncology network

Liberté, Égalité, Fraternité… and a shared commitment to advance cancer research

New strategic partnerships: our global oncology network continues to expand!

Together, we're building the world's most comprehensive database of exceptional cancer survivors

CHUV Lausanne received their Rosalind trophy!

Our partnership with CHUV plays a critical role in advancing our Rosalind Study

Sharing Insights: our CEO Nicolas Wolikow Speaks at PSCC Annual Event!

Biotech startups and pharmaceutical companies can strengthen partnerships to accelerate drug development

How Cure51 Builds a Global Cancer Research Project Across 50+ Countries

Running an international oncology network across 50+ countries requires rigorous coordination and strict clinical research compliance

A Strategic Partnership to Rethink Pancreatic Cancer Treatment: Cure51 × CRCM × Institut Paoli-Calmettes

Celebrating a huge Rosalind Study milestone: 115+ worldwide partner oncology centers!

Rosalind Study Milestone: 115+ Centers Join Cure51’s International Oncology Network

Happy New Year 2026! Reflecting on Cure51’s Cancer Research Progress & the Rosalind Study

Rosalind Study Launches in Dubai to Advance Cancer Research

Rosalind Study Launches in Dubai in collaboration with Mediclinic Middle East City Hospital and Dr. Shaheenah Dawood to Advance Cancer Research

Join us to eradicate Cancer.